The historical rank and industry rank for Ekso Bionics Holdings's FCF Margin % or its related term are showing as below:
EKSO'
s FCF Margin % Range Over the Past 10 Years
Min: -430.87 Med: -106.74 Max: -55.14
Current: -104.95
During the past 13 years, the highest FCF Margin % of Ekso Bionics Holdings was -55.14%. The lowest was -430.87%. And the median was -106.74%.
EKSO's FCF Margin % is ranked worse than 84.42% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.1
vs EKSO: -104.95
Ekso Bionics Holdings FCF Margin % Related Terms
Ekso Bionics Holdings FCF Margin % Historical Data
* Premium members only.
The historical data trend for Ekso Bionics Holdings's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Ekso Bionics Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ekso Bionics Holdings FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ekso Bionics Holdings's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Ekso Bionics Holdings's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ekso Bionics Holdings (EKSO) has a FCF Margin % of -99.16% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Ekso Bionics Holdings and its competitors. According to the industry distribution chart, Ekso Bionics Holdings ranks #688 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 84.4%.
Is Ekso Bionics Holdings' FCF Margin % too high?
Ekso Bionics Holdings' current FCF Margin % is -99.16%. Based on the distribution chart, Ekso Bionics Holdings ranks #688 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Ekso Bionics Holdings has a GF Score™ of 32/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ekso Bionics Holdings' FCF Margin % compare to POCI and HBIO?
According to the Medical Devices & Instruments industry distribution chart, Ekso Bionics Holdings ranks #688 out of 815 companies for FCF Margin %. This places Ekso Bionics Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Ekso Bionics Holdings and its competitors. Ekso Bionics Holdings's current FCF Margin % is -99.16%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ekso Bionics Holdings stock overvalued right now?
Based on GuruFocus' analysis, Ekso Bionics Holdings (EKSO) is currently considered Significantly Overvalued. The stock's GF Value™ is $4.31, compared to a current price of $11.65 — trading 170.3% above its estimated fair value. The current FCF Margin % is -99.16%. Ekso Bionics Holdings' overall GF Score™ is 32/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Ekso Bionics Holdings (EKSO), the current FCF Margin % is -99.16% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ekso Bionics Holdings (EKSO) Overvalued in 2026?
Based on GuruFocus' analysis, Ekso Bionics Holdings stock appears to be overvalued.
The current stock price of $11.65 is trading 170.3% above its estimated GF Value™ of $4.31.
GuruFocus considers Ekso Bionics Holdings to be Significantly Overvalued.
Key valuation signals for EKSO:
FCF Margin %: -99.16%
GF Value™: $4.31 vs. price of $11.65 (170.3% above fair value)
No single metric tells the full story. See the EKSO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.
32GF Score
Get the complete analysis for EKSO
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EKSO has been successfully added to your 
